Direct CEO Access. Curated Research. Zero Noise.
Join verified institutional and accredited investors, family offices, and active market participants accessing small-cap equity research, executive video briefings, and pre-IPO opportunities.
Save Time on Research
Access concise, high-signal company content designed to help investors evaluate opportunities more efficiently.
Hear Directly from Management
Recorded presentations and CEO interviews provide a direct view into company strategy, positioning, and messaging.
Access Curated Opportunities
Cyan Capital focuses on high-quality pre-IPO and emerging public companies that fit our quality criteria.
Chris Parr, MBA
Vetted Access. Zero Noise.
Hosted by Chris Parr, a seasoned investor and public market executive with a career spent navigating every side of a corporate transaction. Cyan Access eliminates traditional promotional noise. Every corporate briefing is a structured, direct-to-management dialogue focused entirely on operational milestones, commercial execution, and institutional clarity.
From Our Research Desk
Independent, unredacted corporate reports and analysis highlighting unique companies positioned for growth.
VitalHub Corp.: Unlocking the Valuation Disconnect
An in-depth analysis of single-payer healthcare capacity constraints, SaaS unit economics, Sri Lankan engineering cost arbitrage, and GAAP profitability transitions.
Nano One Materials: Localizing the Cathode Supply Chain
Evaluating Nano One's patented "One-Pot" synthesis chemistry, Worley Chemetics licensing model, Candiac demo plant scaling, and non-dilutive grant runway.
Perimeter Medical: Transition to Commercial Stage
Early-stage medtech shifting toward recurring procedure revenue. Analysis of real-time surgical margin assessment, FDA PMA validation, and clinical adoption.
Upcoming Corporate Briefings
Cyan Access distributes exclusive direct-to-management video briefings in structured drop-cycles.
Q3 2026: Healthcare Innovation & Scalable MedTech
Direct briefings with emerging management teams executing high-barrier commercialization, clinical advancement, or disruptive tech strategies in North American healthcare markets.
Q4 2026: Industrial Innovation & Advanced Tech
Standardized evaluations of under-recognized infrastructure, high-barrier proprietary tech, advanced materials, and clean-industrial asset scaling.
Are you a corporate executive looking to feature your company?
Present your operational milestones directly to our network of family offices, institutional investors, and accredited partners without sell-side distortion.
Join the Cyan Access Network
Secure instant access to our active research reports, upcoming corporate video briefings, and direct analyst Q&A threads on the portal.
Create Your Access Credentials → 100% Free for public coverage. Takes less than 60 seconds.